Type-I Interferons Inhibit Interleukin-10 Signaling and Favor Type 1 Diabetes Development in Nonobese Diabetic Mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Type-I Interferons Inhibit Interleukin-10 Signaling and Favor Type 1 Diabetes Development in Nonobese Diabetic Mice

Published:2018-07-16 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Iglesias Marcos,Arun Anirudh,Chicco Maria,Lam Brandon,Talbot C. Conover,Ivanova Vera,Lee W. P. A.,Brandacher Gerald,Raimondi Giorgio

Funder

American Diabetes Association

American Association of Immunologists

JDRF

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference51 articles.

1. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat;Castano;Annu Rev Immunol,1990

2. The role for gut permeability in the pathogenesis of type 1 diabetes – a solid or leaky concept?;Li;Pediatr Diabetes,2015

3. Mechanisms of beta cell dysfunction associated with viral infection;Petzold;Curr Diab Rep,2015

4. Where genes meet environment-integrating the role of gut luminal contents, immunity and pancreas in type 1 diabetes;Scott;Transl Res,2017

5. Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes;Shizuru;Science,1988

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell responsiveness to IL-10 defines the immunomodulatory effect of costimulation blockade via anti-CD154 and impacts transplant survival;2024-06-14

2. The Relationship between Type 1 Diabetes Mellitus, TNF-α, and IL-10 Gene Expression;Biomedicines;2023-04-07

3. Design and characterization of lipid nanocarriers for oral delivery of immunotherapeutic peptides;Journal of Biomedical Materials Research Part A;2022-12-30

4. Design and Characterization of Lipid Nanocarriers for Oral Delivery of Immunotherapeutic Peptides;2022-01-28

5. RNA Flow Cytometry for the Study of T Cell Metabolism;International Journal of Molecular Sciences;2021-04-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3